Lung Cancer, An Issue of Hematology/Oncology Clinics
This issue of Hematology/Oncology Clinics will focus on lung cancer; specifically, Genomics in lung cancer; Neoadjuvant and adjuvant therapy for NSCLC; Treatment of locally advanced NSCLC; First line systemic therapy for NSCLC; Second line chemotherapy and beyond for NSCLC; Treatment of EGFR mutant tumors; Treatment of ALK positive tumors; New targets in NSCLC; Immunotherapy; Advances in Small cell lung cancer; and many more!
|Author Information||By Roy S. Herbst, MD, PhD, Yale Comprehensive Cancer Center and Daniel Morgensztern, MD, Washington University School of Medicine|
|Stock Status||In Stock|
Write Your Own Review